AccuNeb (Albuterol Sulfate Nebulizer) is filed as Short-Acting Beta Agonist. The sections below restate public label fields stored for this profile.
Treatment of bronchospasm in patients aged 2 to 12 years with reversible obstructive airway disease
Albuterol sulfate nebulizer solution is a short-acting beta-2 agonist delivered via nebulization. It relaxes bronchial smooth muscle by stimulating beta-2 adrenergic receptors, providing rapid bronchodilation.
May produce paradoxical bronchospasm. Use with caution in cardiovascular disorders. Can cause hypokalemia.
Albuterol tablets are contraindicated in patients with a history of hypersensitivity to albuterol, or any of its components.
Tremors (20%); Dizziness (7%); Nervousness (4%); Headache (3%); Insomnia (1%); Nausea (4%); Dyspepsia (1%); Nasal congestion (1%)
Use of albuterol sulfate may be associated with the following: • Paradoxical bronchospasm [see WARNINGS AND PRECAUTIONS ( 5.1 )] • Cardiovascular Effects [see WARNINGS AND PRECAUTIONS ( 5.4 )] • Immediate hypersensitivity reactions [see WARNINGS AND PRECAUTIONS ( 5.6 )] • Hypokalemia [see WARNINGS AND PRECAUTIONS ( 5.8 )]
The following dosages of albuterol tablets are expressed in terms of albuterol base.
The concomitant use of albuterol tablets and other oral sympathomimetic agents is not recommended since such combined use may lead to deleterious cardiovascular effects. This recommendation does not preclude the judicious use of an aerosol bronchodilator of the adrenergic stimulant type in patients receiving albuterol tablets. Such concomitant use, however, should be individualized and not given on a routine basis. If regular coadministration is required, then alternative therapy should be considered.
According to its FDA label, AccuNeb (Albuterol Sulfate Nebulizer) is approved for: Treatment of bronchospasm in patients aged 2 to 12 years with reversible obstructive airway disease For medical advice, please talk to your prescriber or pharmacist.
AccuNeb (Albuterol Sulfate Nebulizer) belongs to the Short-Acting Beta Agonist class of medications.
The FDA label lists AccuNeb (Albuterol Sulfate Nebulizer) as: Life-threatening paradoxical bronchospasm may occur. Discontinue albuterol sulfate inhalation aerosol immediately and treat with alternative therapy. ( 5.1 ) • Need for more doses of albuterol sulfate inhalation aerosol than usual may be a sign of deterioration of asthma and requires reevaluation of treatment. ( 5.2 ) • Albuterol sulfate is not a substitute for corticosteroids. ( 5.3 ) • Cardiovascular effects may occur. Use with caution in patients sensitive to sympathomimetic drugs and patients with cardiovascular or convulsive disorders. ( 5.4 , 5.7 ) • Excessive use may be fatal. Do not exceed recommended dose. ( 5.5 ) • Immediate hypersensitivity reactions may occur. Discontinue albuterol sulfate inhalation aerosol immediately. ( 5.6 ) • Hypokalemia and changes in blood glucose may occur. ( 5.7 , 5.8 ); respiratory (inhalation) route. Available strengths and packaging vary by manufacturer.
Yes. A generic version of AccuNeb (Albuterol Sulfate Nebulizer) is available in the U.S. Ask your pharmacist about substitution.
Our ingest of the FDA label for AccuNeb (Albuterol Sulfate Nebulizer) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for AccuNeb (Albuterol Sulfate Nebulizer) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for AccuNeb (Albuterol Sulfate Nebulizer) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for AccuNeb (Albuterol Sulfate Nebulizer) as 1997-09-17.
The FDA label lists Asclemed USA, Inc. as a labeler/manufacturer of AccuNeb (Albuterol Sulfate Nebulizer). Multiple firms may market generics of the same molecule.
The FDA label states: "Albuterol tablets, USP; 2 mg of albuterol as the sulfate, are white, round, scored, debossed MP 47 Bottles of 100 NDC 53489-176-01 Bottles of 500 NDC 53489-176-05 Albuterol tablets, USP; 4 mg of albuterol as the sulfate,…" Follow the packaging insert for the authoritative guidance.
The FDA label lists a pregnancy category of C for AccuNeb (Albuterol Sulfate Nebulizer). Pregnancy and lactation decisions should be made with a clinician.
Loading full data from Know Your Drugs Institute…